Dietary protein insufficiency: an important consideration in fatty liver disease?
Study Goal
The researchers aimed to explore the relationship between low dietary protein intake, branched-chain amino acids (BCAAs), and their effects on liver lipid accumulation, gut microbiota function, and fatty liver disease.
Results Summary
The study found that BCAAs can modulate gut microbiome composition and metabolic activity, potentially influencing protective odd-chain fatty acid (OCFA) and short-chain fatty acid (SCFA) production in the liver. Preclinical animal models showed that specific amino acid supplementation, including BCAAs, could ameliorate fatty liver disease induced by low-protein diets.
Population
Preclinical animal models (specific species not mentioned) and vulnerable groups in developing countries with dietary protein restriction.
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
Dietary protein insufficiency | increase | excessive TAG storage and non-alcoholic fatty liver disease (NAFLD) | developing countries | - | has been linked to | #1 |
low-protein diet | decrease | peroxisomal, mitochondrial and gut microbiota function | - | - | may be due to altered | #2 |
propionate and butyrate | decrease | obesity, insulin resistance and NAFLD | - | - | concentrations correlate inversely with risk of | #3 |
The methyl donor amino acid composition of dietary protein | neutral | liver function and lipid storage | - | - | is an important contributor to | #4 |
dietary branched-chain amino acids | neutral | the composition and metabolic activity of the gut microbiome | - | - | can modulate | #5 |
dietary branched-chain amino acids | neutral | protective OCFA and SCFA production in the liver | - | - | can affect | #6 |
specific amino acid supplementation | decrease | fatty liver disease | preclinical animal models fed with low-protein diets | - | can ameliorate | #7 |
Dietary protein insufficiency has been linked to excessive TAG storage and non-alcoholic fatty liver disease (NAFLD) in developing countries. Hepatic TAG accumulation following a low-protein diet may be due to altered peroxisomal, mitochondrial and gut microbiota function. Hepatic peroxisomes and mitochondria normally mediate metabolism of nutrients to provide energy and substrates for lipogenesis. Peroxisome biogenesis and activities can be modulated by odd-chain fatty acids (OCFA) and SCFA that are derived from gut bacteria, for example, propionate and butyrate. Also produced during amino acid metabolism by peroxisomes and mitochondria, propionate and butyrate concentrations correlate inversely with risk of obesity, insulin resistance and NAFLD. In this horizon-scanning review, we have compiled available evidence on the effects of protein malnutrition on OCFA production, arising from loss in mitochondrial, peroxisomal and gut microbiota function, and its association with lipid accumulation in the liver. The methyl donor amino acid composition of dietary protein is an important contributor to liver function and lipid storage; the presence and abundance of dietary branched-chain amino acids can modulate the composition and metabolic activity of the gut microbiome and, on the other hand, can affect protective OCFA and SCFA production in the liver. In preclinical animal models fed with low-protein diets, specific amino acid supplementation can ameliorate fatty liver disease. The association between low dietary protein intake and fatty liver disease is underexplored and merits further investigation, particularly in vulnerable groups with dietary protein restriction in developing countries.